C-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for mitoxantrone- and anisomycin-induced apoptosis in HL-60 cells

Leukemia Research

Volumn 26, Issue 1, 2002, Pages 55-65

  Stadheim, Terrance A ^a   Kucera, Gregory L ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; ERK; JNK SAPK; p38; SB203580

Indexed keywords

ANISOMYCIN; DNA FRAGMENT; MITOXANTRONE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; SIGNAL PROCESSING; WESTERN BLOTTING;

ANISOMYCIN; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; DNA, NEOPLASM; FLAVONOIDS; HL-60 CELLS; HUMANS; IMIDAZOLES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LEUKEMIA, MYELOID; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MITOXANTRONE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PRECIPITIN TESTS; PROTEIN SYNTHESIS INHIBITORS; PYRIDINES; TRANSFECTION;

EID: 0036131785     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(01)00099-6     Document Type: Article

References (50)

1. Control of the ERK MAP kinase cascade by Ras and Raf
2. Tumor necrosis factor alpha stimulates AP-1 activity through prolonged activation of the c-Jun kinase
3. Anticancer drugs acting against signaling pathways
4. jun-NH2-terminal kinase activation mediated by UV-induced DNA lesions in melanoma and fibroblast cells
5. The role of c-Jun N-terminal kinase in apoptosis induced by ultraviolet C and gamma radiation-duration of JNK activation may determine cell death and proliferation
6. The stress-activated protein kinase subfamily of c-Jun kinases
7. Involvement of stress-activated protein kinase in the cellular response to 1-β-D-arabinofuranosylcytosine and other DNA-damaging agents
8. Activation of JNK/SAPK pathway is not directly inhibitory for cell cycle progression in NIH3T3 cells
9. Adriamycin activates c-Jun N-terminal kinase in human leukemia cells-a relevance to apoptosis
10. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat
11. The stress-activated protein kinase pathway
12. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38
13. Mitogen-activated protein kinase kinase 7 is an activator of the c-Jun NH2-terminal kinase
14. Activation of stress-activated protein kinases/c-Jun N-terminal protein kinases (SAPKs/JNKs) by a novel mitogen-activated protein kinase kinase
15. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells
16. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
17. An osmosensing signal transduction pathway in yeast
18. Components of a new human protein kinase signal transduction pathway
19. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
20. Drug-target interactions: only the first step in the commitment to a programmed cell death?
21. Apoptosis in cancer therapy: crossing the threshold
22. Apoptosis induced by anticancer drugs
23. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation
24. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages
25. Apoptosis. Its significance in cancer and cancer therapy
26. The cell-death machine
27. Overexpression of Bcl-2 or Bcl-X(L) inhibits ara-C-induced CPP32/YAMA protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells
28. Protein kinase CbetaII activation by 1-beta-D-arabinofuranosylcytosine is antagonistic to stimulation of apoptosis and bcl-2alpha down-regulation
29. Ribotoxic stress response-activation of the stress-activated protein kinase JNK1 by inhibitors of the peptidyl transferase reaction and by sequence-specific RNA damage to the alpha-sarcin/ricin loop in the 28S rRNA
30. High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells
31. Ceramide, daunorubicin, sphingolipid signaling pathwa, sphingomyelin. daunorubicin-induced apoptosis-triggering of ceramide generation through sphingomyelin hydrolysis
32. Extracellular signal-regulated kinase (ERK) activity is required for TPA-mediated inhibition of drug-induced apoptosis
33. Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site
34. Death of tumor cells after intracellular acidification is dependent on stress-activated protein kinases (SAPK/JNK) pathway activation and cannot be inhibited by Bcl-2 expression or interleukin 1beta-converting enzyme inhibition
35. Inhibition of extracellular signal-regulated kinase (ERK) mediates cell cycle phase independent apoptosis in vinblastine-treated ML-1 cells
36. Signalling and superinduction
37. Activation of c-Jun N-terminal kinase antagonizes an anti- apoptotic action of Bcl-2
38. High-dose mitoxantrone induces programmed cell death or apoptosis in human myeloid leukemia cells
39. Selective activation of caspases during apoptotic induction in HL-60 cells. Effects of a tetrapeptide inhibitor
40. 1-beta-D-arabinofuranosylcytosine-, mitoxantrone-, and paclitaxel-induced apoptosis in HL-60 cells: improved method for detection of internucleosomal DNA fragmentation
41. Ceramide activates the stress-activated protein kinases
42. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway
43. p38 mitogen-activated protein kinase-dependent and-independent intracellular signal transduction pathways leading to apoptosis in human neutrophils
44. Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells
45. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase
46. Role of c-Jun N-terminal kinase/p38 stress signaling in 1-beta-D-arabinofuranosylcytosine-induced apoptosis
47. Human mitogen-activated protein kinase kinase 7 (MKK7) is a highly conserved c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) activated by environmental stresses and physiological stimuli
48. A novel SAPK/JNK kinase, MKK7, stimulated by TNFalpha and cellular stresses
49. c-Jun NH2-terminal kinase-mediated activation of interleukin-1-beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis
50. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1